Kitty Dukakis, the wife of Democratic presidential nominee Michael Dukakis, has died at the age of 88 from dementia ...

The number of cases will increase, but the rates seem to be declining with every birth cohort that reaches advanced ages, ...

For some people with a high risk of Alzheimer's who received a drug called gantenerumab for eight years, their risk of ...

Leqembi is an infusion therapy that targets and removes the beta-amyloid plaque that builds up in the brains of Alzheimer's patients.

Vascular dementia occurs when blood vessels that deliver blood to the brain become damaged. Our blood contains oxygen and nutrients that help the brain cells to work properly. When blood vessels are ...

A long-term human trial has found that a discontinued drug halved the presentation of early-onset Alzheimer's disease in ...

While the clinical dementia findings did not reach statistical significance, they were the first to provide a hint that early ...

An experimental drug appears to reduce the risk of Alzheimer's-related dementia in people destined to develop the disease in their 30s, 40s or 50s, according to the results of a new study. The ...

An early Alzheimer's treatment that removes amyloid plaques from the brain many years before symptoms arise may help delay ...

Researchers followed a small group of 22 patients who had genetic mutations that cause the overproduction of amyloid in the ...

Medication options are available to help manage the cognitive and behavioral symptoms of dementia and Alzheimer's disease.

The new findings center on a subset of 22 participants who received amyloid-removing drugs the longest, on average eight years. Long-term amyloid removal cut in half their risk of symptom onset, ...